Abstract
Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients with type 2 diabetes. We conducted a post hoc analysis to compare the efficacy and safety of atorvastatin among 1,129 patients aged 65-75 years at randomization with 1,709 younger patients in the Collaborative Atorvastatin Diabetes Study (CARDS).
Original language | English |
---|---|
Pages (from-to) | 2378-2384 |
Number of pages | 7 |
Journal | Diabetes Care |
Volume | 29 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2006 |